DaVita
DVA
#1913
Rank
A$15.30 B
Marketcap
A$243.28
Share price
3.00%
Change (1 day)
36.03%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): A$20.21

According to DaVita's latest financial reports the company's current EPS (TTM) is A$20.97. In 2025 the company made an earnings per share (EPS) of A$15.29 a decrease over its 2024 EPS that were of A$16.66.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$20.2132.16%
2025A$15.29-8.25%
2024A$16.6644.94%
2023A$11.5027.26%
2022A$9.03-35.56%
2021A$14.0244.1%
2020A$9.7319.7%
2019A$8.13540.48%
2018A$1.27-76.07%
2017A$5.30-19.31%
2016A$6.57242.52%
2015A$1.92-62.87%
2014A$5.1713.43%
2013A$4.568.45%
2012A$4.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
A$36.50 74.06%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$18.54-11.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
A$52.44 150.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$2.85-86.41%๐Ÿ‡บ๐Ÿ‡ธ USA